Pakistan launches Phase III trials for Chinese Cansinobio’s COVID-19 vaccine


Pakistan has launched Phase III clinical trials for CanSino Biologics’ COVID-19 vaccine candidate, a government minister and an official at the Chinese pharmaceutical company said on Tuesday.

Pakistan gave the go-ahead for the country’s first Phase-III clinical trial in August for CanSino’s candidate, Ad5-nCoV, led by the government-run National Institute of Health (NIH) and pharmaceutical company AJM – the local representative of CanSino.

“Just launched the Phase III trials for a COVID-19 vaccine in Pakistan,” said the minister for planning, Asad Umar, who also oversees command and control operations headed by the country’s military to combat the coronavirus outbreak.

He said a total of 40,000 people across seven countries will participate in the trial, including up to 10,000 in Pakistan. Initial results are expected in four to six months, the minister said in a tweeted statement. US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.


Our new page here is just what you need, with just good news, feel good stories unrelated to COVID.

By Justgivemepositivenews Team